(Rac)-JBJ-04-125-02 T8872
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
JBJ-04-125-02 is effective as a single agent in both in vitro and in vivo models of EGFR-mutant lung cancer.
CAS nr:
2140807-05-0
Purity:
98%
Molecular Weight:
543,6
SMILES:
C1CN(CCN1)C2=CC=C(C=C2)C3=CC4=C(CN(C4=O)C(C5=C(C=CC(=C5)F)O)C(=O)NC6=NC=CS6)C=C3
Formula:
C29H26FN5O3S
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling
Target:
EGFR,EGFR,EGFR
